These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 10333199)

  • 1. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.
    Woywodt A; Ludwig D; Neustock P; Kruse A; Schwarting K; Jantschek G; Kirchner H; Stange EF
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):267-76. PubMed ID: 10333199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease.
    Woywodt A; Neustock P; Kruse A; Schwarting K; Ludwig D; Stange EF; Kirchner H
    Eur Cytokine Netw; 1994; 5(4):387-95. PubMed ID: 7841354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear neutrophils and their mediators in gingival tissues from generalized aggressive periodontitis.
    Liu RK; Cao CF; Meng HX; Gao Y
    J Periodontol; 2001 Nov; 72(11):1545-53. PubMed ID: 11759866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
    Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
    J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
    Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
    Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.
    Dionne S; Hiscott J; D'Agata I; Duhaime A; Seidman EG
    Dig Dis Sci; 1997 Jul; 42(7):1557-66. PubMed ID: 9246063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
    Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
    J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
    Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
    Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cytokines and vascular adhesion receptors in the pathology of fronto-ethmoidal mucocoeles.
    Lund VJ; Henderson B; Song Y
    Acta Otolaryngol; 1993 Jul; 113(4):540-6. PubMed ID: 7691023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells.
    Youngman KR; Simon PL; West GA; Cominelli F; Rachmilewitz D; Klein JS; Fiocchi C
    Gastroenterology; 1993 Mar; 104(3):749-58. PubMed ID: 8440434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease.
    Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Caprioli F; Monteleone I; Zorzi F; De Nitto D; Colantoni A; Biancone L; Pallone F; Monteleone G
    PLoS One; 2013; 8(7):e69839. PubMed ID: 23922818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
    Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
    Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease.
    Arai F; Takahashi T; Furukawa K; Matsushima K; Asakura H
    Dig Dis Sci; 1998 Sep; 43(9):2071-9. PubMed ID: 9753275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
    Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
    J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the phenotype of colonic macrophages in inflammatory bowel disease.
    Rogler G; Andus T; Aschenbrenner E; Vogl D; Falk W; Schölmerich J; Gross V
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):893-9. PubMed ID: 9355789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.
    Stevens C; Walz G; Singaram C; Lipman ML; Zanker B; Muggia A; Antonioli D; Peppercorn MA; Strom TB
    Dig Dis Sci; 1992 Jun; 37(6):818-26. PubMed ID: 1587185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.